Biosino Bio-Technology and Science Incorporation (HKG:8247)

Market Cap	99.85M
Revenue (ttm)	279.95M
Net Income (ttm)	-45.26M
Shares Out	144.71M
EPS (ttm)	-0.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8,300
Open	0.6900
Previous Close	0.6900
Day's Range	0.6900 - 0.6900
52-Week Range	0.2600 - 1.3800
Beta	-0.74
RSI	54.76
Earnings Date	Aug 8, 2025

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation founded in 1988 and is based in Beijing, the Pe...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1988
• Employees: 499
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8247

Financial Performance

In 2024, HKG:8247's revenue was 263.07 million, a decrease of -9.00% compared to the previous year's 289.07 million. Losses were -42.53 million, 265.1% more than in 2023.

Financial numbers in CNY